EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Somatic Mutation Trajectories Define Prognostically Distinct Subtypes and Shape the Tumor Microenvironment in Gastric Cancer

Yikang Shen, Huaxin Pang iD, Haiyu Liu, Pengzhen Ma, Mingrui Liu, Yaning Li, Qihao Wang, Xiaoxia Xie, Xiaoping Zhang, Yufeng Zhao

Genes · 30.04.2026 · 17 (5) · 536

DOI: 10.3390/genes17050536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 30.04.2026. Verfasst von Yikang Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Data Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor Microenvironment, Mutation, Biomarkers, Tumor. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Project of the China Academy of Chinese Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Gastric cancer (GC) is characterized by molecular heterogeneity, yet current classifications are largely based on cross-sectional molecular profiles and do not account for the temporal order of mutation accumulation. This study aimed to reconstruct somatic mutation trajectories to identify prognostically distinct subtypes and to examine transcriptomic and microenvironmental features associated with these inferred trajectories.

Methods

We applied the Subtype and Stage Inference (SuStaIn) algorithm to TCGA-STAD somatic mutation data to infer the temporal sequence of mutation accumulation. Stage-correlated gene expression analysis was performed to identify genes whose expression levels changed with evolutionary stage. The tumor microenvironment (TME) was characterized using EcoTyper and single-cell RNA sequencing deconvolution, while drug sensitivity was estimated through transcriptome-based IC50 prediction. The clinical relevance of the inferred trajectories was further evaluated in three independent external transcriptomic cohorts.

Results

We identified two distinct evolutionary trajectories: the Accelerated Path (AP, 65%) and the Gradual Path (GP, 35%). In the AP, TP53 mutations were positioned at an earlier evolutionary stage (Stage 3) compared to the GP (Stage 8). AP patients had significantly worse overall survival (Hazard Ratio = 1.437, p = 0.044, adjusted for clinical stage and molecular subtypes). The AP was associated with stage-correlated downregulation of the sodium channel gene SCN4A (ρ = −0.36, p < 0.001) and an increase in a squamous-associated gene expression score, while the GP showed stage-correlated expression changes in the mitochondrial gene SDHD (ρ = −0.35, p < 0.001). The AP was further characterized by higher inferred abundance of extracellular matrix CAFs (eCAFs) and lower inferred immune cell scores, whereas the GP was associated with higher inferred signatures of activated B cells and effector memory T cells. Computational drug sensitivity modeling predicted a negative correlation between AP stage and IC50 values for 5-Fluorouracil and Docetaxel.

Conclusions

Two distinct mutational ordering patterns identified by SuStaIn are associated with divergent transcriptomic features, TME compositions, and clinical outcomes in gastric cancer. The AP subtype is characterized by early TP53 mutations, SCN4A downregulation, and a stromal-enriched microenvironment, while the GP subtype is associated with later TP53 mutations, SDHD-correlated expression, and higher inferred immune cell scores. The reproducibility of these associations was confirmed in independent cohorts. The computational drug sensitivity predictions and the proposed mechanistic links between gene expression patterns and clinical outcomes should be viewed as hypothesis-generating findings that require prospective and functional validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsTumor MicroenvironmentMutationBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticTranscriptomeGene Expression Profiling

Stichwörter der Autor:innen

computational genomicsgastric cancersomatic mutation trajectoriestumor evolutiontumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Data Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.

ORCID-Profile: Huaxin Pang

Förderung

  • National Natural Science Foundation of China
  • Innovation Project of the China Academy of Chinese Medical Sciences

Zitieren

APA

Shen, Y., Pang, H., Liu, H., Ma, P., Liu, M., Li, Y., Wang, Q., Xie, X., Zhang, X., & Zhao, Y. (2026). Somatic Mutation Trajectories Define Prognostically Distinct Subtypes and Shape the Tumor Microenvironment in Gastric Cancer. Genes, 17(5), 536. https://doi.org/10.3390/genes17050536

Vancouver

Shen Y, Pang H, Liu H, Ma P, Liu M, Li Y, et al. Somatic Mutation Trajectories Define Prognostically Distinct Subtypes and Shape the Tumor Microenvironment in Gastric Cancer. Genes. 2026;17(5):536. doi:10.3390/genes17050536

BibTeX
@article{Shen2026,
  author = {Shen, Yikang and Pang, Huaxin and Liu, Haiyu and Ma, Pengzhen and Liu, Mingrui and Li, Yaning and Wang, Qihao and Xie, Xiaoxia and Zhang, Xiaoping and Zhao, Yufeng},
  title = {Somatic Mutation Trajectories Define Prognostically Distinct Subtypes and Shape the Tumor Microenvironment in Gastric Cancer},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {536},
  doi = {10.3390/genes17050536}
}
Kostenlos starten →